Intravenous Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Component, By End-Use Industry, By Region and Competition, 2020-2030F

Description

Global Intravenous (IV) Hydration Therapy Market was valued at USD 3.26 Billion in 2024 and is expected to reach USD 4.98 Billion by 2030 with a CAGR of 7.32% during the forecast period. Intravenous (IV) Hydration Therapy is a medical treatment that involves delivering fluids, electrolytes, and sometimes medications directly into a person's bloodstream through a vein. It is commonly used to address dehydration and various medical conditions. Intravenous (IV) hydration is often employed to treat moderate to severe dehydration, which can occur due to illnesses, excessive sweating, vomiting, diarrhoea, or inadequate fluid intake. IV fluids quickly replenish the body's fluid levels, helping to restore electrolyte balance and maintain proper organ function. IV hydration therapy can help manage the fluid and electrolyte imbalances that can arise from certain illnesses, such as gastroenteritis, kidney infections, and urinary tract infections. Electrolytes are essential minerals (such as sodium, potassium, calcium, and magnesium) that play a crucial role in maintaining various bodily functions, including nerve and muscle function, fluid balance, and pH regulation. IV hydration therapy can correct imbalances in electrolyte levels, which can be caused by conditions like kidney dysfunction, hormonal disorders, or severe vomiting and diarrhoea.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.26 Billion
Market Size 2030	USD 4.98 Billion
CAGR 2025-2030	7.32%
Fastest Growing Segment	Medicated segment
Largest Market	North America

Key Market Drivers

Increasing Surgical Procedures Drives the Market Growth

Increasing surgical procedures drive the growth of the global Intravenous (IV) hydration therapy market primarily due to the essential role that IV hydration therapy plays in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. Prior to surgery, patients often need to fast or restrict their oral fluid intake, which can lead to dehydration. IV hydration therapy is used to ensure that patients are adequately hydrated before surgery, which is important for maintaining stable blood pressure, optimal organ function, and overall patient well-being. During surgery, patients may experience fluid and electrolyte shifts due to blood loss, fluid shifts, and the effects of anaesthesia. IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's ability to respond to surgical stress and anaesthesia. After surgery, patients may experience nausea, vomiting, and limited oral intake, which can lead to further dehydration. IV hydration therapy is essential for supporting the recovery process, preventing complications, and facilitating the healing process. Proper hydration and electrolyte balance are key factors in reducing the risk of postoperative complications, such as infections, wound healing issues, and organ dysfunction. IV hydration therapy can help minimize these risks and improve overall patient outcomes. Adequate hydration and electrolyte balance are associated with faster healing and recovery times. IV hydration therapy can help patients regain their strength and energy more quickly after surgery, allowing them to resume normal activities sooner.

Key Market Challenges

Regulatory and Legal Considerations

Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market due to the need to ensure patient safety, maintain quality standards, and adhere to local and international regulations governing medical practices and the administration of medical treatments. Healthcare providers who administer IV hydration therapy need to hold the appropriate licenses and certifications to perform medical procedures. These requirements vary by jurisdiction and can involve extensive training and education. Obtaining and maintaining these credentials can be time-consuming and costly. Different healthcare professionals have varying scopes of practice when it comes to administering IV therapies. Legal and regulatory frameworks may restrict who is allowed to perform IV therapy, which can impact the availability and accessibility of the treatment.

Key Market Trends

Rise of Wellness and Lifestyle Use

In global Intravenous (IV) Hydration Therapy market, The rise of wellness and lifestyle use is a significant trend in the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. The trend has expanded the potential consumer base beyond traditional medical indications. Wellness-conscious individuals, athletes, professionals with demanding lifestyles, and those seeking quick recovery from fatigue or exertion are exploring IV hydration therapy for its perceived benefits. The trend aligns with a growing interest in holistic health and well-being. Consumers are viewing IV hydration therapy as a complementary approach to maintaining overall health, alongside other wellness practices such as diet, exercise, and stress management. Many individuals seek IV hydration therapy to boost energy levels and combat fatigue. The treatment is believed to provide a quick and efficient way to rehydrate and replenish essential nutrients, leading to improved vitality and performance. IV hydration therapy is often marketed as a way to support the immune system, particularly during times of stress, travel, or exposure to illness. Consumers may opt for IV treatments to enhance their body's defenses and well-being. IV hydration therapy is perceived as a convenient and time-efficient method of receiving hydration and nutrients. This appeals to busy individuals who seek immediate results.

Key Market Players

Core IV Therapy, LLC
Rejuvenated UK Ltd.
B. Braun Medical Inc.
Otsuka Pharmaceutical Co., Ltd.
NexGen Health Inc
JW Life Science Corporation
Amanta Healthcare Ltd
Baxter International Inc.
Drip Hydration Inc.
Becton, Dickinson and Company

Report Scope:

In this report, Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

Immune Boosters
Energy Boosters
Skin Care
Migraine
Others

Intravenous (IV) Hydration Therapy Market, By Component:

Medicated
Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

Hospitals & Clinics
Wellness Centers & Spas
Home Healthcare
Others

Intravenous (IV) Hydration Therapy Market, By region:

North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
- 5.2.2. By Component (Medicated, Non-medicated)
- 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Service
- 6.2.2. By Component
- 6.2.3. By End-Use Industry
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Service
    - 6.3.1.2.2. By Component
    - 6.3.1.2.3. By End-Use Industry
- 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Service
    - 6.3.2.2.2. By Component
    - 6.3.2.2.3. By End-Use Industry
- 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Service
    - 6.3.3.2.2. By Component
    - 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Service
- 7.2.2. By Component
- 7.2.3. By End-Use Industry
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Service
    - 7.3.1.2.2. By Component
    - 7.3.1.2.3. By End-Use Industry
- 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Service
    - 7.3.2.2.2. By Component
    - 7.3.2.2.3. By End-Use Industry
- 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Service
    - 7.3.3.2.2. By Component
    - 7.3.3.2.3. By End-Use Industry
- 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Service
    - 7.3.4.2.2. By Component
    - 7.3.4.2.3. By End-Use Industry
- 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Service
    - 7.3.5.2.2. By Component
    - 7.3.5.2.3. By End-Use Industry

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Service
- 8.2.2. By Component
- 8.2.3. By End-Use Industry
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Service
    - 8.3.1.2.2. By Component
    - 8.3.1.2.3. By End-Use Industry
- 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Service
    - 8.3.2.2.2. By Component
    - 8.3.2.2.3. By End-Use Industry
- 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Service
    - 8.3.3.2.2. By Component
    - 8.3.3.2.3. By End-Use Industry
- 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Service
    - 8.3.4.2.2. By Component
    - 8.3.4.2.3. By End-Use Industry
- 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Service
    - 8.3.5.2.2. By Component
    - 8.3.5.2.3. By End-Use Industry

9. South America Intravenous (IV) Hydration Therapy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Service
- 9.2.2. By Component
- 9.2.3. By End-Use Industry
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Service
    - 9.3.1.2.2. By Component
    - 9.3.1.2.3. By End-Use Industry
- 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Service
    - 9.3.2.2.2. By Component
    - 9.3.2.2.3. By End-Use Industry
- 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Service
    - 9.3.3.2.2. By Component
    - 9.3.3.2.3. By End-Use Industry

10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Service
- 10.2.2. By Component
- 10.2.3. By End-Use Industry
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Service
    - 10.3.1.2.2. By Component
    - 10.3.1.2.3. By End-Use Industry
- 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Service
    - 10.3.2.2.2. By Component
    - 10.3.2.2.3. By End-Use Industry
- 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Service
    - 10.3.3.2.2. By Component
    - 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape

15.1. Core IV Therapy, LLC
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (In case of listed companies)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Cryojuvenate UK Ltd.
15.3. B. Braun Medical Inc.
15.4. Otsuka Pharmaceutical Co., Ltd.
15.5. NexGen Health Inc
15.6. JW Life Science Corporation
15.7. Amanta Healthcare Ltd
15.8. Baxter International Inc.
15.9. Drip Hydration Inc
15.10. Becton, Dickinson and Company